Virtus Investment Advisers’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-40,689
Closed -$1.61M 689
2024
Q4
$1.61M Sell
40,689
-15,109
-27% -$572K 1.26% 10
2024
Q3
$1.9M Buy
55,798
+5,983
+12% +$168K 1.49% 7
2024
Q2
$1.08M Hold
49,815
0.91% 18
2024
Q1
$1.1M Buy
49,815
+5,851
+13% +$143K 0.79% 24
2023
Q4
$1.21M Buy
43,964
+31,100
+242% +$751K 0.91% 21
2023
Q3
$287K Hold
12,864
0.2% 130
2023
Q2
$328K Buy
12,864
+6,326
+97% +$153K 0.22% 125
2023
Q1
$146K Buy
+6,538
New +$158K 0.1% 218

Other funds holding VCYT

Virtus Investment Advisers's VCYT Position: Q1 2025 in Review

Virtus Investment Advisers sold out of Veracyte (VCYT) in Q1 2025, closing a stake of 40,689 shares — an estimated $1.61M sold.

Virtus Investment Advisers first reported a position in VCYT in Q1 2023 and held it in 8 quarters. The position peaked at $1.9M in Q3 2024. 287 funds tracked by Wall St. Rank hold VCYT as of Q1 2025.

  • Virtus Investment Advisers reported no remaining Veracyte position as of Q1 2025 after selling out during the quarter.
  • Virtus Investment Advisers sold 40,689 Veracyte shares in Q1 2025, an estimated $1.61M.
  • Virtus Investment Advisers first reported a position in Veracyte in Q1 2023 and held it in 8 quarters.
  • Virtus Investment Advisers's Veracyte position peaked at $1.9M in Q3 2024.
  • 287 funds tracked by Wall St. Rank held Veracyte as of Q1 2025.

Based on Virtus Investment Advisers's 13F filing for Q1 2025, filed 15 May 2025.